Pluri Inc. Operating Expenses
Pluri Inc. (PLUR) reported Operating Expenses of $4.95 million for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2013-11-05
- Pluri Inc. operating expenses for the quarter ending 2013-09-30 was $4.95M, a 13.09% increase year-over-year.
- Pluri Inc. operating expenses for the quarter ending 2012-09-30 was $4.38M, a 2.39% decline year-over-year.
- Pluri Inc. operating expenses for the quarter ending 2012-06-30 was $4.07M, a 6.12% increase year-over-year.
- Pluri Inc. operating expenses for the quarter ending 2012-03-31 was $4.84M, a 79.33% increase year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2013-09-30 | $4.95M 10-Q · filed 2013-11-05 | |||
| 2012-09-30 | $4.38M 10-Q · filed 2013-11-05 | $8.45M derived: sum of 2 quarters · filed 2013-11-05 | $13.29M derived: sum of 3 quarters · filed 2013-11-05 | $15.64M derived: sum of 4 quarters · filed 2013-11-05 |
| 2012-06-30 | $4.07M 10-K · filed 2012-09-10 | $8.91M derived: sum of 2 quarters · filed 2012-09-10 | $11.26M derived: sum of 3 quarters · filed 2012-09-10 | $15.75M derived: sum of 4 quarters · filed 2012-09-10 |
| 2012-03-31 | $4.84M 10-K · filed 2012-09-10 | $7.19M derived: sum of 2 quarters · filed 2012-09-10 | $11.68M derived: sum of 3 quarters · filed 2012-09-10 | $15.51M derived: sum of 4 quarters · filed 2012-09-10 |
| 2011-12-31 | $2.35M 10-K · filed 2012-09-10 | $6.83M derived: sum of 2 quarters · filed 2012-09-10 | $10.67M derived: sum of 3 quarters · filed 2012-09-10 | $13.37M derived: sum of 4 quarters · filed 2012-09-10 |
| 2011-09-30 | $4.49M 10-K · filed 2012-09-10 | $8.32M derived: sum of 2 quarters · filed 2012-09-10 | $11.02M derived: sum of 3 quarters · filed 2012-09-10 | $13.85M derived: sum of 4 quarters · filed 2012-09-10 |
| 2011-06-30 | $3.84M 10-K · filed 2012-09-10 | $6.54M derived: sum of 2 quarters · filed 2012-09-10 | $9.36M derived: sum of 3 quarters · filed 2012-09-10 | $11.11M derived: sum of 4 quarters · filed 2012-09-10 |
| 2011-03-31 | $2.70M 10-K · filed 2012-09-10 | $5.52M derived: sum of 2 quarters · filed 2012-09-10 | $7.28M derived: sum of 3 quarters · filed 2012-09-10 | |
| 2010-12-31 | $2.82M 10-K · filed 2012-09-10 | $4.58M derived: sum of 2 quarters · filed 2012-09-10 | ||
| 2010-09-30 | $1.75M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |